Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

MDM2 promoter SNP344T>A (rs1196333) status does not affect cancer risk.

Knappskog S, Gansmo LB, Romundstad P, Bjørnslett M, Trovik J, Sommerfelt-Pettersen J, Løkkevik E, Tollenaar RA, Seynaeve C, Devilee P, Salvesen HB, Dørum A, Hveem K, Vatten L, Lønning PE. MDM2 promoter SNP344T>A (rs1196333) status does not affect cancer risk. PLoS One. 2012; 7(4):e36263.

View in: PubMed

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.